Tamar Grossman

Company: The Janssen Pharmaceutical Companies of Johnson & Johnson

Job title: Global Head of RNA & Targeted Therapeutics

Seminars:

Panel Discussion – Delivery Carriers for Efficient siRNA Therapies 9:45 am

With the development of new carrier technologies for delivery of siRNA therapeutics, there is a greater need to understand better formulation and mechanistic strategies to enhance efficacy and reduce toxicity. From design to development, we will delve deeper into techniques beyond GalNac for effective siRNA therapeutic delivery How to design novel carriers to reduce toxicity…Read more

day: Day One